Clinical Research Directory
Browse clinical research sites, groups, and studies.
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
Sponsor: Centre Hospitalier Universitaire de Nīmes
Summary
This study aims at investigating if adjunctive buprenorphine at low dose to treatment as usual is effective in reducing severe suicidal ideas in major depressive episode, and at determining the most effective dose.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2021-10-10
Completion Date
2027-01
Last Updated
2025-08-21
Healthy Volunteers
No
Interventions
Buprenorphine
Buprenorphine, 0.4mg pills, sublingual
Placebo
Placebo pills, sublingual, specifically made to mimick buprenorphine pills
Locations (9)
Ch Perrens
Bordeaux, France, France
CHU Bicêtre
Le Kremlin-Bicêtre, France
Hospices Civils de Lyon
Lyon, France
CAPPA Jacques PREVERT
Nantes, France
CHU Nîmes
Nîmes, France
CH Sainte-Anne
Paris, France
CH Henri Laborit
Poitiers, France
Chu Toulouse Hopital Purpan
Toulouse, France
CHU de Tours
Tours, France